|
 |
moxifloxacin HClThis page contains recent news articles, when available, and an overview of moxifloxacin HCl but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.Overview: moxifloxacin HCl (when available) Moxifloxacin is a quinolone/fluoroquinolone antibiotic. Moxifloxacin is bactericidal and its mode of action depends on blocking of bacterial DNA replication by binding itself to an enzyme called DNA gyrase, which allows the untwisting required to replicate one DNA double helix into two. Notably the drug has 100 times higher affinity for bacterial DNA gyrase than for mammalian. Moxifloxacin is a broad-spectrum antibiotic that is active against both Gram-positive and Gram-negative bacteria. For the treatment of bacterial conjunctivitis caused by susceptible strains of the following organisms: Corynebacterium species* Acinetobacter lwoffii* Micrococcus luteus* Haemophilus influenzae Staphylococcus aureus Haemophilus parainfluenzae* Staphylococcus epidermidis Staphylococcus haemolyticus Staphylococcus hominis Chlamydia trachomatis Staphylococcus warneri* Streptococcus pneumoniae Mechanism Of Action: The bactericidal action of Moxifloxacin results from inhibition of the enzymes topoisomerase II (DNA gyrase) and topoisomerase IV, which are required for bacterial DNA replication, transcription, repair, and recombination. News Articles on Moxifloxacin … Approves New Indication for Avelox (moxifloxacin HCl) for Treatment... - Nov 30, 2005 KENILWORTH, NJ -- November 30, 2005 -- Schering-Plough Corporation today announced that the US Food and Drug Administration (FDA) has approved the ... DG News … FDA Approval of Avelox MOXIFLOXACIN HCL for Treatment of … - Jul 6, 2005 ...and Drug Administration (FDA) has approved the once-daily antibiotic AVELOX® (moxifloxacin HCl) for the treatment of complicated skin and skin structure ... DentalPlans.com Press Release: Head-To-Head Study Shows More Elderly Patients With … - Jan 24, 2006 Article: FDA Approves Avelox(R) (moxifloxacin HCl) for Community ... PR Newswire; March 4, 2003 ; 700+ words ... ... PRNewswire/ -- The United States Food ... Pay-Per-View - PR Newswire - HighBeam Research … New Indication for AVELOX(R) (moxifloxacin HCl) for Treatment of … - Nov 30, 2005 FDA Approves New Indication for AVELOX(R) (moxifloxacin HCl) for Treatment of Complicated Intra-Abdominal Infections (cIAI). from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research FDA approves AVELOX (moxifloxacin HCl) for treatment of complicated … - Nov 28, 2005 Schering-Plough Corporation (NYSE: SGP) today announced that the US Food and Drug Administration (FDA) has approved the once-daily, broad-spectrum ... PsychCentral.com … FDA Approval of AVELOX(R) (moxifloxacin HCl) for Treatment of … - Jun 30, 2005 Schering-Plough Announces FDA Approval of AVELOX(R) (moxifloxacin HCl) for Treatment of Complicated Skin and Skin Structure Infections. from PR Newswire. Pay-Per-View - PR Newswire - HighBeam Research Head-To-Head Study Shows More Elderly Patients With Community- … - Jan 24, 2006 24 /PRNewswire-FirstCall/ -- Significantly more elderly patients treated with AVELOX(R) (moxifloxacin HCl) for community-acquired pneumonia (CAP) recovered ... Free with registration - PR Newswire - AccessMyLibrary.com … Confirm Excellent Speed Of Eradication By Avelox(R) (moxifloxacin... - May 29, 2006 A recently published study in the peer-reviewed online journal BMC Ear, Nose and Throat disorders found that Avelox(R) (moxifloxacin HCl) eradicated all ... Medical News Today - Medical News Today (press release) FDA Approvals: Rozerem, Synera, Avelox IV - Jul 28, 2005 On June 13, the FDA approved a new indication for moxifloxacin HCl ... This indication for moxifloxacin HCl injection (Avalox IV) was approved by the ... Medscape FDA Approvals: Avelox, Avandaryl, Trileptal - Dec 1, 2005 On November 22, the FDA approved a new indication for moxifloxacin HCl (Avelox tablets and injection, made by Bayer Healthcare AG), allowing its use for the ... Medscape International Approvals: Retaane, Avelox, Generic Zinnat - Dec 19, 2005 On December 9, moxifloxacin HCl 400-mg tablets (Avelox, marketed by Shionogi and Company, Ltd, under license from Bayer Yakuhin, Ltd) were launched on the ... Medscape Press Release: AVELOX(R) Monotherapy as Effective as High-Dose … - Apr 7, 2006 Article: FDA Approves Avelox(R) (moxifloxacin HCl) for Community ... PR Newswire; March 4, 2003 ; 700+ words ... ... PRNewswire/ -- The United States Food ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Efficacy of Once-Daily AVELOX(R) in Treating … - Sep 29, 2006 Article: FDA Approves New Indication for AVELOX(R) (moxifloxacin HCl) for ... PR Newswire; November 30, 2005 ; 700+ words ... ... treatment of complicated ... Pay-Per-View - PR Newswire - HighBeam Research Press Release: Study Shows Once-Daily AVELOX(R) as Effective as Multi... - Jul 25, 2006 Article: FDA Approves New Indication for AVELOX(R) (moxifloxacin HCl) for ... PR Newswire; November 30, 2005 ; 700+ words ... ... treatment of complicated ... Pay-Per-View - PR Newswire - HighBeam Research SP's 2nd-quarter 2007 EPS doubles to $0.34.(Schering-Plough revenue … - Jul 30, 2007 Among other prescription products posting higher sales was the antibiotic Avelox (moxifloxacin HCl), originated by Germany's Bayer, which jumped 30% to ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Antibiotic can lessen chronic bronchitis from smoking - Nov 20, 2007 In the GIANT study, the participants were made to take 400 mg of Avelox (Bayer's own moxifloxacin HCl formula) once a day for five days while doctors ... Inquirer.net Avelox® Monotherapy Shows Strong Performance In Treating … - May 19, 2008 A recently published study in Clinical Infectious Diseases shows that Avelox® (moxifloxacin HCl) monotherapy is as powerful as a high dose combination ... Medical News Today - Medical News Today (press release) Schering-Plough antibiotic 'effective' in abdomen treatments - Oct 3, 2006 Patients suffering from complicated intra-abdominal infections (cIAI) have shown a positive reaction to the Avelox (moxifloxacin HCl) antibiotic, ... Hays Pharma LegalView Reveals Details of the FDA Mandated Black Box - Jul 11, 2008 Finally, adult patients who have been taking Avelox (moxifloxacin HCL) for treatment of either bacterial sinusitis, bronchitis or pneumonia infections ... TransWorldNews - TransWorldNews (press release) Press Release: Bayer/Schering-Plough/Shionogi's Avelox Has … - Apr 17, 2008 24 ... moxifloxacin HCl) for community-acquired pneumonia (CAP) recovered at days 3 to 5 ... study, called CAPRIE (Community-Acquired Pneumonia Recovery In ... Pay-Per-View - PR Newswire - HighBeam Research Bayer sues over Teva's US generic Avelox.(Teva Pharmaceuticals USA … - Apr 16, 2007 German drug major Bayer has sued the US unit of Israeli generic giant Teva for allegedly infringing the patent on Avelox (moxifloxacin HCl), as Teva plans ... $4.95 - Pharma Marketletter - ECNext Press Release: New Study Supports Use of LEVAQUIN as a Guideline- … - Oct 27, 2008 PR Newswire; January 24, 2006 ; 700+ words ... ... moxifloxacin HCl) for community-acquired pneumonia (CAP) recovered at days 3 to ... CAP. ... Pay-Per-View - PR Newswire - HighBeam Research Article: Biologic marker can help tailor antibiotic use in CAP.(Infect... - Jun 1, 2007 24 ... moxifloxacin HCl) for community-acquired pneumonia (CAP) recovered at days 3 to 5 ... study, called CAPRIE (Community-Acquired Pneumonia Recovery In ... Pay-Per-View - Internal Medicine News - HighBeam Research Efficacy of Once-Daily Moxifloxacin in Treating Complicated Intra- … - Oct 13, 2006 SAN FRANCISCO, CA -- October 13, 2006 -- The efficacy of monotherapy with the once-daily, broad-spectrum antibiotic Avelox® (moxifloxacin HCl) in the ... DG News Bayer sues over Teva's US generic Avelox. - Apr 16, 2007 German drug major Bayer has sued the US unit of Israeli generic giant Teva for allegedly infringing the patent on Avelox (moxifloxacin HCl), as Teva plans ... $9.94 - Pharma Marketletter - Alacra Store Young contact lens wearer presents with pain, injection and decreased... - Oct 1, 2006 The patient was advised to suspend contact lens use and was started on Vigamox drops (moxifloxacin HCl ophthalmic solution 0.5%, Alcon) every hour and ... OSN SuperSite Press Release: Drugs from Johnson & Johnson/Basilea and Forest Are … - Nov 19, 2007 24 ... moxifloxacin HCl) for community-acquired pneumonia (CAP) recovered at days 3 to 5 ... study, called CAPRIE (Community-Acquired Pneumonia Recovery In ... Pay-Per-View - PR Newswire - HighBeam Research Schering-Plough Media Alert: Data on Schering-Plough Anti-Infectives... - Dec 13, 2005 Study results also will be reported for AVELOX(R) (moxifloxacin HCl), a once-daily, broad-spectrum antibiotic that is approved in the United States and ... RedOrbit Vaccinated Senior Citizens Less Likely to Die from Pneumonia - Mar 16, 2006 America's senior citizens 65 and older, but there appears to be new hope in this battle from a newer antibiotic, moxifloxacin HCl, marketed as Avelox. ... SeniorJournal.com FDA approves Schering-Plough's Avelox for treatment of skin infections - Jul 2, 2005 The US FDA has approved the once-daily antibiotic Avelox (moxifloxacin HCl) of Schering-Plough Corporation for the treatment of complicated skin and skin ... pharmabiz.com Efficacy of once-daily Avelox for complicated abdominal infections … - Sep 29, 2006 29, 2006 – The efficacy of monotherapy with the once-daily, broad-spectrum antibiotic AVELOX® (moxifloxacin HCl) in the treatment of complicated ... eurekalert.org Avelox® IV Approved in Europe to Treat Complicated Skin and Skin … - Jul 31, 2005 Bayer HealthCare announced that Avelox® IV (moxifloxacin HCl, solution for Infusion) was approved for the treatment of complicated Skin and Skin Structure ... i-newswire.com Quest for New Antibiotics to Fight Drug Resistant Infections Gets... - Sep 12, 2006 America's senior citizens 65 and older, but there appears to be new hope in this battle from a newer antibiotic, moxifloxacin HCl, marketed as Avelox. ... SeniorJournal.com DLK more likely than infection: the risk of developing DLK after a... - Nov 15, 2005 This patient should also be treated prophylactically with an antibiotic drop, such as Zymar or Vigamox (moxifloxacin HCl ophthalmic solution, ... Free with registration - Review of Optometry - AccessMyLibrary.com Monotherapie mit Avalox® zeigt sehr gute Ergebnisse bei der stationäre... - May 15, 2008 ..."Clinical Infectious Diseases" publizierte Studie zeigt, dass die Monotherapie mit Avalox® (Moxifloxacin-HCl) bei der stationären Behandlung... ... pressebox.de Alcon and Allergan Reach Agreement on Brimonidine 0.15% Patent … - Mar 9, 2006 Alcon believes this suit was intended to target Vigamox(R) (0.5% moxifloxacin HCl ophthalmic solution), Alcon's leading ophthalmic ocular antibiotic in the ... Free with registration - Business Wire - AccessMyLibrary.com Avelox(R) IV Approved in Europe to Treat Complicated Skin and Skin … - Jul 26, 2005 Bayer HealthCare announced that Avelox(R) IV (moxifloxacin HCl, solution for Infusion) was approved for the treatment of complicated Skin and Skin Structure ... Medical News Today - Medical News Today (press release) AVELOX(R) Monotherapy as Effective as High-Dose Levofloxacin and … - Apr 7, 2006 KENILWORTH, NJ, April 7 /PRNewswire-FirstCall/ -- AVELOX(R) (moxifloxacin HCl) monotherapy at 400 mg once daily is as effective as the high-dose combination ... Free with registration - PR Newswire - AccessMyLibrary.com Antibiotic for skin infections.(PRODUCTS) - Oct 1, 2005 Avelox (moxifloxacin HCl) tablets are indicated for treating complicated skin infections in adults caused by methicillin-susceptible Staphylococcus aureus, ... Free with registration - OB GYN News - AccessMyLibrary.com Avelox as Effective as Multi-Dose Combination Therapy for Intra- … - Jul 25, 2006 ...broad-spectrum antibiotic Avelox (moxifloxacin HCl) was as effective and well tolerated as a standard multi-dose combination antibiotic regimen in the ... DG News Severe Community-Acquired Pneumonia - Avelox(R) Monotherapy As … - Apr 10, 2006 AVELOX(R) (moxifloxacin HCl) monotherapy at 400 mg once daily is as effective as the high-dose combination of levofloxacin (500 mg twice daily) plus ... Medical News Today - Medical News Today (press release) Avelox As Effective As Multi-dose Combination Therapy For Intra- … - Jul 28, 2006 Schering-Plough Corporation (NYSE: SGP) today reported that monotherapy with the once-daily, broad-spectrum antibiotic AVELOX (moxifloxacin HCl) was as ... Medical News Today - Medical News Today (press release) Scherings AVELOX Shown Effective in Study and Merck Announces … - Jul 26, 2006 Schering-Plough Corporation (NYSE: SGP) recently reported that monotherapy with the once-daily, broad-spectrum antibiotic AVELOX (moxifloxacin HCl) was as ... Free with registration - M2 Presswire - AccessMyLibrary.com S-Ps Avelox outperforms Levaquin in CAP study.(Schering-Plough Corp.)... - Feb 6, 2006 A study published in the current issue Clinical Infectious Diseases shows that more elderly patients treated with Avelox (moxifloxacin HCl), ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Treat as bacterial infection until fungus is positive, experts... - May 15, 2006 Dr. Mah recommended starting patients on an antibiotic such as moxifloxacin HCl ophthalmic solution 0.5% (Vigamox, Alcon Laboratories) or gatifloxacin 0.3% ... Free with registration - Ophthalmology Times - AccessMyLibrary.com New indications. - Jan 9, 2006 A sixth indication has been approved for the fluoroquinolone antibiotic Avelox (moxifloxacin HCl), developed by Bayer and marketed in the United States by ... $9.94 - Drug Topics - Alacra Store Japan stock market week to Oct 17. - Oct 24, 2005 ...had received approval to import Avelox (moxifloxacin HCl), a new quinolone antibacterial agent for the treatment of respiratory tract infections. ... $4.95 - Pharma Marketletter - ECNext Schering-Plough; Recent developments from Schering-Plough detailed - Dec 5, 2006 Report 3: Schering-Plough Corporation (SGP) reported that monotherapy with the once-daily, broad-spectrum antibiotic Avelox (moxifloxacin HCl) was as ... Pay-Per-View - Life Science Weekly - Factiva, from Dow Jones Bayer drug better than leading pneumonia treatment - Jan 31, 2006 Significantly more elderly patients treated with the Bayer drug Avelox (moxifloxacin HCl) for community-acquired pneumonia (CAP) recovered at days three to ... Pay-Per-View - Datamonitor News and Comment - Factiva, from Dow Jones Schering-Plough announces FDA approval of AVELOX and Corixa … - Jul 5, 2005 ...and Drug Administration (FDA) has approved the once-daily antibiotic AVELOX (moxifloxacin HCl) for the treatment of complicated skin and skin structure ... $4.95 - M2 Presswire - ECNext Shionogi's 2005 sales 196.4B yen, down 1.5%. - May 29, 2006 2005 launch and the antibacterial agent Avelox (moxifloxacin HCl) that it licenses from Germany's Bayer, which produced 1.8 billion yen in sales. ... $9.94 - Pharma Marketletter - Alacra Store SP announces positive Avelox study data.(Schering-Plough Corp.)(Brief... - Apr 17, 2006 US drugmaker Schering-Plough says that the antibiotic Avelox (moxifloxacin HCl), which it markets in the USA in partnership with the drug's German ... $4.95 - Pharma Marketletter - ECNext Press Release: Scherings AVELOX Shown Effective in Study and Merck … - Jul 26, 2006 Schering-Plough Corporation (NYSE: SGP) recently reported that monotherapy with the once-daily, broad-spectrum antibiotic AVELOX (moxifloxacin HCl) was as ... Pay-Per-View - M2 Presswire - HighBeam Research Bayer's Avelox approved for cSSSI in EU.(Bayer HealthCare AG's … - Aug 15, 2005 Germany's Bayer HealthCare says that its prescription antibiotic Avelox IV (moxifloxacin HCl, solution for infusion) has been approved for the treatment of ... $4.95 - Pharma Marketletter - ECNext FDA OKs SP/Bayer's Avelox for 6th indication.(Brief Article) - Dec 12, 2005 The US Food and Drug Administration has approved German drugmaker Bayer's antibiotic Avelox (moxifloxacin HCl) for a new indication, the treatment of ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones Bayer's Avelox "as effective" as potent combo regimen for CA pneumonia... - Sep 11, 2006 Germany's Bayer AG says that sequential intravenous to oral monotherapy with its antibiotic Avelox (moxifloxacin HCl) 400mg, once a day, is as effective as ... $9.94 - Pharma Marketletter - Alacra Store Press Release: The University of Texas Study: Newer Antibiotic More … - Jan 24, 2006 Pharma Marketletter; February 6, 2006 ; 700+ words ... ... moxifloxacin HCl), for community-acquired pneumonia, recovered at days three to ... of Texas ... Pay-Per-View - PR Newswire - HighBeam Research Factiva Search - Sep 29, 2006 The efficacy of monotherapy with the once-daily, broad-spectrum antibiotic Avelox (moxifloxacin HCl) in the treatment ... ... Pay-Per-View - Company Reports - Factiva, from Dow Jones Article: Alter pneumonia strategies to fight resistance.(Infectious... - Dec 1, 2005 PR Newswire; January 24, 2006 ; 700+ words ... ... elderly population with community-acquired pneumonia KENILWORTH, N.J ... moxifloxacin HCl) for ... Pay-Per-View - Family Practice News - HighBeam Research Article: Advisers Suggest Restricting Antibiotic - AP Online |... - Dec 16, 2006 Biotech Week; November 24, 2004 ; 700+ words ...2004 NOV 24 - (NewsRx.com & NewsRx.net) -- A new study showed the antibiotic Avelox (moxifloxacin HCl) was ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Article: Advisers Suggest Restricting Antibiotic - AP Online |... - Dec 16, 2006 Biotech Week; November 24, 2004 ; 700+ words ...2004 NOV 24 - (NewsRx.com & NewsRx.net) -- A new study showed the antibiotic Avelox (moxifloxacin HCl) was ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Factiva Search - Apr 7, 2006 Avelox (moxifloxacin HCl) monotherapy at 400 mg once daily is as effective as the high-dose combination of levofloxacin ... ... Pay-Per-View - Company Reports - Factiva, from Dow Jones Press Release: Phase 2 and 3 Clinical Data for Bifeprunox in Patients... - Dec 6, 2006 ...acute exacerbations of chronic bronchitis (AECB) who took a five-day course of the antibiotic Avelox (moxifloxacin HCl) achieved a greater clinical ... ... Pay-Per-View - PR Newswire - HighBeam Research Shionogi's six-month income drops 23%. - Nov 20, 2006 Revenue from Avelox (moxifloxacin HCl), Shionogi's new quinolone antibiotic, and Finibax (doripenem), a carbapenem antibiotic, which were launched in 2005, ... $9.94 - Pharma Marketletter - Alacra Store Article: Advisers Suggest Restricting Antibiotic - AP Online |... - Dec 15, 2006 Biotech Week; November 24, 2004 ; 700+ words ...2004 NOV 24 - (NewsRx.com & NewsRx.net) -- A new study showed the antibiotic Avelox (moxifloxacin HCl) was ... Pay-Per-View - Associated Press/AP Online - HighBeam Research Brand Names/Synonyms: moxifloxacin HCl is also known by the following brand names and/or synonymsAvelox; Avelox I.V.; CHEMBANK1636; Moxifloxacin; Moxifloxacin Hcl; Moxifloxacin Hydrochloride; Vigamox Drug Category: moxifloxacin HCl is categorized under the following by the FDA: Anti-bacterial Agents; Quinolones; ATC:J01MA14 Dosage Forms: SOLUTION; TABLET Absorption: Not Available Interactions: [an error occurred while processing this directive] Chemical IUPAC Name: 1-cyclopropyl-7-(5,8-diazabicyclo[4.3.0]non-8-yl)-6-fluoro-8-methoxy-4-oxo-1H-quinoline-3-carboxylicacid |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |
